{"organizations": [], "uuid": "d3283ffe9f1b76fb47ec7d4def1f682a31fc00dd", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "https://www.reuters.com/legal", "section_title": "Legal News | Reuters", "url": "https://www.reuters.com/article/health-aveo/ex-aveo-pharmaceuticals-cfo-must-face-sec-trial-judge-rules-idUSL1N1RX1VY", "country": "US", "domain_rank": 408, "title": "Ex-Aveo Pharmaceuticals CFO must face SEC trial, judge rules", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.001, "site_type": "news", "published": "2018-04-21T05:30:00.000+03:00", "replies_count": 0, "uuid": "d3283ffe9f1b76fb47ec7d4def1f682a31fc00dd"}, "author": "Nate Raymond", "url": "https://www.reuters.com/article/health-aveo/ex-aveo-pharmaceuticals-cfo-must-face-sec-trial-judge-rules-idUSL1N1RX1VY", "ord_in_thread": 0, "title": "Ex-Aveo Pharmaceuticals CFO must face SEC trial, judge rules", "locations": [], "entities": {"persons": [{"name": "david johnston", "sentiment": "none"}, {"name": "nathaniel gorton", "sentiment": "none"}], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "sec", "sentiment": "negative"}, {"name": "u.s. securities and exchange commission", "sentiment": "negative"}, {"name": "eo pharmaceuticals inc", "sentiment": "none"}, {"name": "u.s. food and drug administration", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "A federal judge on Friday cleared the way for the U.S. Securities and Exchange Commission to take Aveo Pharmaceuticals Inc’s former chief financial officer to trial over claims he misled investors in connection with the company’s efforts to develop a cancer drug.\nU.S. District Judge Nathaniel Gorton declined to dismiss the case against former Aveo CFO David Johnston, saying jurors should decide whether the drugmaker should have disclosed communications it had with the U.S. Food and Drug Administration.\nTo read the full story on WestlawNext Practitioner Insights, click here: bit.ly/2HGw7Tu\n 0 : 0 narrow-browser-and-phone medium-browser-and-portrait-tablet landscape-tablet medium-wide-browser wide-browser-and-larger medium-browser-and-landscape-tablet medium-wide-browser-and-larger above-phone portrait-tablet-and-above above-portrait-tablet landscape-tablet-and-above landscape-tablet-and-medium-wide-browser portrait-tablet-and-below landscape-tablet-and-below Apps Newsletters Reuters Plus Advertising Guidelines Cookies Terms of Use Privacy\nAll Quote: s delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.\n© 2018 Reuters. All Rights Reserved.", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "http://bit.ly/2HGw7Tu", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-21T05:30:00.000+03:00", "crawled": "2018-04-21T10:33:25.002+03:00", "highlightTitle": ""}